sulfasalazine has been researched along with Hypersensitivity, Type III in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axelsson, LG | 2 |
| Ahlstedt, S | 2 |
2 other studies available for sulfasalazine and Hypersensitivity, Type III
| Article | Year |
|---|---|
Characteristics of immune-complex-induced chronic experimental colitis in rats with a therapeutic effect of sulphasalazine.
Topics: Animals; Chronic Disease; Colitis, Ulcerative; Disease Models, Animal; Female; Immune Complex Diseas | 1990 |
Immune complex induced experimental colitis: beneficial effect of sulphasalazine in rabbits.
Topics: Animals; Antibodies; Antibodies, Bacterial; Colitis; Cross Reactions; Escherichia coli; Female; Immu | 1990 |